|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.64 CNY | -1.07% |
|
-4.55% | -9.68% |
| 06-09 | China Approves Aodong Subsidiary's Levocarnitine Injection | MT |
| 05-21 | Jilin Aodong Pharmaceutical Gets China Approval for Supplemental Registration of Heart Drug | MT |
| Market Cap | 20.68B 3.05B 2.67B 2.46B 2.27B 4.31B 291B 4.39B 29.4B 11.55B 143B 11.45B 11.2B 493B | P/E 2024 |
13.1x | P/E 2025 | 9.57x |
|---|---|---|---|---|---|
| Enterprise Value | 19.96B 2.94B 2.57B 2.37B 2.19B 4.16B 281B 4.23B 28.37B 11.14B 138B 11.05B 10.81B 475B | EV / Sales 2024 |
7.76x | EV / Sales 2025 | 9.49x |
| Free-Float |
67.59% | Yield 2024 |
2.9% | Yield 2025 | 2.56% |
| 1 day | -1.07% | ||
| 1 week | -4.55% | ||
| Current month | -0.51% | ||
| 1 month | +1.44% | ||
| 3 months | -3.29% | ||
| 6 months | -13.23% | ||
| Current year | -9.68% |
| 1 week | 17.32 |  | 18.7 |
| 1 month | 17.08 | | 18.88 |
| Current year | 16.36 | | 20.93 |
| 1 year | 16.36 | | 22.08 |
| 3 years | 12.49 | | 22.08 |
| 5 years | 12.49 | | 22.08 |
| 10 years | 12.49 | | 29.43 |
| Manager | Title | Age | Since |
|---|---|---|---|
Shu Qin Guo
CEO | Chief Executive Officer | 63 | 2017-07-16 |
Kai Yang
DFI | Director of Finance/CFO | 49 | 2004-04-30 |
Shu Yuan Zhang
DFI | Director of Finance/CFO | 54 | 2007-06-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Xiu Lin Li
CHM | Chairman | 73 | 2005-05-17 |
Shu Qin Guo
BRD | Director/Board Member | 63 | 2000-01-31 |
Yong Feng Chen
CHM | Chairman | 59 | 2017-07-16 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11-24 | Buy | 100 | 0.0000% | |||
| 24-07-28 | Buy | Chief Executive Officer | 320,000 | 0.0276% | ||
| 24-07-28 | Buy | Chairman | 350,000 | 0.0302% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.07% | -4.55% | -0.62% | +12.43% | 3.05B | |
| +0.08% | -1.10% | +48.48% | +173.03% | 1,060B | |
| +0.12% | -0.45% | +64.63% | +62.57% | 619B | |
| -0.31% | -2.61% | +29.55% | +85.72% | 438B | |
| -0.70% | +0.81% | +29.80% | +25.00% | 333B | |
| +0.26% | -0.40% | +29.21% | +47.28% | 282B | |
| -1.39% | -10.13% | +18.85% | +22.67% | 267B | |
| +0.23% | +0.31% | -27.33% | -38.40% | 218B | |
| -1.11% | -1.56% | +21.44% | +58.44% | 196B | |
| -0.54% | -0.29% | +15.29% | +68.47% | 161B | |
| Average | -0.36% | -3.60% | +22.93% | +51.72% | 357.7B | |
| Weighted average by Cap. | -0.12% | -3.10% | +35.84% | +84.30% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.61B 385M 337M 311M 287M 544M 36.72B 554M 3.71B 1.46B 18.09B 1.45B 1.41B 62.19B | 2.34B 344M 301M 278M 257M 487M 32.85B 495M 3.32B 1.3B 16.18B 1.29B 1.26B 55.63B |
| Net income | 1.55B 229M 200M 185M 170M 324M 21.82B 329M 2.21B 866M 10.75B 859M 840M 36.96B | 2.4B 353M 309M 285M 263M 499M 33.69B 508M 3.41B 1.34B 16.6B 1.33B 1.3B 57.06B |
| Net Debt | -386M -56.92M -49.79M -45.93M -42.42M -80.49M -5.43B -81.84M -549M -215M -2.67B -214M -209M -9.19B | -724M -107M -93.4M -86.15M -79.57M -151M -10.18B -154M -1.03B -404M -5.02B -401M -392M -17.25B |
Employees
5,461
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-10 | CN¥17.64 | -1.07% | 14,006,300 |
| 26-07-09 | CN¥17.83 | +0.73% | 12,360,059 |
| 26-07-08 | CN¥17.70 | -1.99% | 10,420,598 |
| 26-07-07 | CN¥18.06 | -3.73% | 13,183,515 |
| 26-07-06 | CN¥18.76 | +1.52% | 18,041,470 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 000623 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
